Navigation Links
BioDelivery Sciences to Host Buprenorphine Investor and Analyst Event
Date:2/27/2013

nt of opioid dependence.  Dr. Bailey is Assistant Clinical Professor of Psychiatry and Human Behavior at The Warren Alpert Medical School of Brown University and Director of Research and Medical Director of the Dual Diagnosis Unit at Stanley Street Treatment and Resources, Inc (SSTAR). 

All three experts will be on the panel and have participated in either the BEMA Buprenorphine chronic pain or BNX opioid addiction programs and will be able to offer their perspectives based on "hands on" experiences.

Management presentations will focus on the clinical programs and the market opportunity for BEMA Buprenorphine for the treatment of moderate to severe chronic pain, and BNX for the management of opioid dependence.  

BDSI and its commercial partner, Endo Health Solutions, continue to enroll patients in the ongoing Phase 3 clinical trials for BEMA Buprenorphine.  Both studies are anticipated to be completed by late 2013 or early 2014.  Additionally, the Company expects to file the New Drug Application (NDA) for BNX with the U.S. Food and Drug Administration (FDA) in mid-2013. 

Institutional investors and analysts may register to attend by contacting Brian Korb (bkorb@troutgroup.com).  Interested parties may access the live presentation on the BioDelivery Sciences website at www.bdsi.com.  A webcast will also be available for 30 days following the event. 

About BioDelivery Sciences International

BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics. 
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences to Present at the 15th Annual BIO CEO and Investor Conference
2. BioDelivery Sciences Announces Completion of BNX Safety Study
3. BioDelivery Sciences Announces $40 Million Registered Financing
4. BioDelivery Sciences to Present at the 24th Annual Piper Jaffray Healthcare Conference
5. BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
6. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
7. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
8. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
9. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
10. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
11. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Massachusetts , 21. Mai 2013 /PRNewswire/ ... („OSI"), die die Firmen OMNIlife science® Inc., Enztec ... zählt, hat zwei neue, erfahrene Mitglieder in ... , eine erfahrene Führungspersönlichkeit aus der ... David Johnson , anerkannter ...
(Date:5/21/2013)... May 21, 2013  LCA-Vision Inc. (NASDAQ: LCAV ... the Lasik Plus ® brand, announces that all nominees to ... at today,s annual meeting of stockholders.  These Directors are: ... President of Bahl & Gaynor Investment Counsel , ... , Edgar F. Heizer III , ...
(Date:5/21/2013)... 21, 2013  Decision Resources, one of ... for pharmaceutical and healthcare issues, finds that ... key efficacy endpoints, including overall survival and ... influence over surveyed U.S. and European oncologists, ... HER2-negative breast cancer. The two novel emerging ...
Breaking Medicine Technology:Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2
... VILLAGE, Colo. , June 28 Recondo ... the healthcare industry, announced today the general availability of ... and disparate hospital systems, applications, software services, and databases. ... developed decades ago, hospitals have been forced to deploy ...
... 28 Reportlinker.com announces that a new market research report is available in its ... Global Melanoma Therapeutics industry , ... http://www.reportlinker.com/p0197206/Global-Melanoma-Therapeutics-industry.html , ... analyzes the worldwide markets for Melanoma Therapeutics in US$ Million. The report provides separate comprehensive ...
Cached Medicine Technology:Recondo Technology Announces Integration Initiative for US Hospital Systems 2Recondo Technology Announces Integration Initiative for US Hospital Systems 3Recondo Technology Announces Integration Initiative for US Hospital Systems 4Global Melanoma Therapeutics Industry 2Global Melanoma Therapeutics Industry 3Global Melanoma Therapeutics Industry 4Global Melanoma Therapeutics Industry 5Global Melanoma Therapeutics Industry 6Global Melanoma Therapeutics Industry 7Global Melanoma Therapeutics Industry 8Global Melanoma Therapeutics Industry 9Global Melanoma Therapeutics Industry 10Global Melanoma Therapeutics Industry 11Global Melanoma Therapeutics Industry 12
(Date:5/22/2013)... 22, 2013 In partnership with ... Surge, LLC, E-Dentists.com has launched a new SEO ... feature numerous topics of interest to dentists and ... dental health. , http://www.E-Dentists.com/Blog/ , Blogging ... marketing. In addition to addressing keyword placement and ...
(Date:5/22/2013)... May 22, 2013 Teams who focus ... improvements use the new Do-Done StepTracker whiteboard as a ... the Do-Done board to display the current status of ... production cells and departments is listed down the side ... start a project, the squares are filled with yellow ...
(Date:5/22/2013)... MA New research from Brigham and Women,s Hospital ... fibrosis, an uncommon but deadly lung disease, may be ... These findings will be presented at the American ... the New England Journal of Medicine on ... 2013 print edition., "While this variant of the MUC5B ...
(Date:5/22/2013)... John Mathews from the University of Melbourne said this ... the undoubted benefits from CT scans in diagnosing and ... the British Medical Journal today and involved ... and the International Agency for Research on Cancer in ... were very useful in providing detailed three dimensional pictures ...
(Date:5/22/2013)... 21 May 2013, Paris, France: Results from ... 2013 today question whether bivalirudin is superior ... blockade, showing similar 30-day mortality in patients ... (NSTE-ACS) undergoing percutaneous coronary intervention (PCI)., European ... alone as an alternative to unfractionated heparin ...
Breaking Medicine News(10 mins):Health News:Dental SEO Blog Launched by E-Dentists.com in Partnership with JD Media Surge, LLC 2Health News:Project Managers Organize Manufacturing Projects and Training with the New Steptracker Project Status Magnetic Whiteboards 2Health News:Genetic marker associated with risk for pulmonary fibrosis 2Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:Registry questions superiority of bivalirudin over heparin 2
... study has found that Hypnotherapy can be used to relieve ... ,In a small study researchers randomly divided 28 patients ... group received 12 sessions of hypnotherapy over 17 weeks while ... placebo or dummy medicine. , ,According to the BMJ, ...
... Endocrinologists (AACE) Fifteenth Annual Meeting and Clinical Congress to ... 26-30 will discuss important benefits //of vitamin D and ... ,Vitamin D has been in the new ... has been attributed to it. Recent studies have highlighted ...
... According to a large study by Boston University, Black women ... greater risk of breast cancer.// ,The study was published ... Medicine., ,This study is unique because there are previous ... and so it would benefit. ,Lead researcher Dr. Lynn ...
... Madhya Pradesh fell ill after feasting at a marriage dinner, ... police said Thursday. // ,While 65 affected people ... after first aid, a hospital spokesman said. ,Earlier, ... feast. ,While many of those admitted to hospital ...
... have found a link between diet and ALS saying ... progression of Amyotrophic Lateral Sclerosis (ALS). // The Mount ... a correlation between diet and neuronal cell death, the ... an adult-onset neurodegenerative disorder in which spinal and cortical ...
... funded the sex-swap surgery of a former sailor is now ... Bainbridge, 57, from Middleton, says she needs the ?2,500 laser ... wear sleevless dresses in the summer. ,Middleton and ... is waiting for a date for surgery at Charing Cross ...
Cached Medicine News:
... plate system is a family of plates ... provides for consistent, reliable fixation of plate ... or backout. This innovative design eliminates the ... implant your screws and the swivel ring ...
... is a leading provider of telemedicine ... with state-of-the-art technology deliver accurate, reliable ... healthcare professionals and clients in improving ... and ECG technology to gather patient ...
... a high performance temperature controlled shaker which ... speed and incubation time are fully programmable ... are displayed on the LCD in real ... the microplates provide uniform incubation with less ...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Medicine Products: